211 | Humans |
175 | Antibodies, Monoclonal, Humanized |
133 | Female |
105 | Male |
103 | Arthritis, Rheumatoid |
101 | Antirheumatic Agents |
97 | Middle Aged |
75 | Treatment Outcome |
74 | Adult |
62 | Aged |
37 | Antibodies, Monoclonal |
34 | Drug Therapy, Combination |
30 | Tumor Necrosis Factor-alpha |
29 | Severity of Illness Index |
29 | Interleukin-6 |
29 | Glucocorticoids |
27 | Methotrexate |
27 | Biological Products |
25 | Retrospective Studies |
25 | Receptors, Interleukin-6 |
25 | Immunosuppressive Agents |
19 | Rituximab |
18 | Giant Cell Arteritis |
17 | Prospective Studies |
16 | Remission Induction |
16 | Abatacept |
15 | Follow-Up Studies |
14 | Young Adult |
14 | Prednisone |
14 | Adolescent |
13 | France |
13 | Biomarkers |
12 | Time Factors |
12 | Still's Disease, Adult-Onset |
12 | Biological Therapy |
12 | Animals |
11 | Double-Blind Method |
11 | Disease Progression |
11 | Cytokines |
11 | Child |
11 | Adrenal Cortex Hormones |
10 | Takayasu Arteritis |
10 | Risk Factors |
10 | Prognosis |
10 | Arthritis, Juvenile |
9 | Polychondritis, Relapsing |
9 | Inflammation |
9 | Immunologic Factors |
9 | Etanercept |
9 | Drug Resistance |
9 | C-Reactive Protein |
9 | Aged, 80 and over |
9 | Adalimumab |
8 | Risk Assessment |
8 | Polymyalgia Rheumatica |
8 | Infusions, Intravenous |
8 | Anti-Inflammatory Agents |
7 | Uveitis |
7 | Recurrence |
7 | Injections, Subcutaneous |
7 | Drug Administration Schedule |
7 | Cohort Studies |
7 | Child, Preschool |
6 | Randomized Controlled Trials as Topic |
6 | Mice |
6 | Infliximab |
6 | Drug Eruptions |
6 | Castleman Disease |
6 | Behcet Syndrome |
5 | Registries |
5 | Outcome Assessment, Health Care |
5 | Joints |
5 | Incidence |
5 | Immunocompromised Host |
5 | Drug Substitution |
5 | Diagnosis, Differential |
5 | Clinical Trials as Topic |
5 | Chronic Disease |
5 | Biological Factors |
5 | Antibodies, Monoclonal, Murine-Derived |
4 | Tomography, X-Ray Computed |
4 | T-Lymphocytes, Regulatory |
4 | Surveys and Questionnaires |
4 | Spondylitis, Ankylosing |
4 | Scleroderma, Systemic |
4 | Rheumatic Diseases |
4 | Radiography |
4 | Psoriasis |
4 | Positron-Emission Tomography |
4 | Phenotype |
4 | Multivariate Analysis |
4 | Molecular Targeted Therapy |
4 | Macrophage Activation Syndrome |
4 | Lymphohistiocytosis, Hemophagocytic |
4 | Interleukins |
4 | Immunoconjugates |
4 | Herpesvirus 4, Human |
4 | Fever |
4 | Europe |
4 | Drug-Related Side Effects and Adverse Reactions |
4 | Drug Monitoring |
4 | Dose-Response Relationship, Drug |
4 | Disease Models, Animal |
4 | Disease Management |
4 | Cardiovascular Diseases |
4 | Body Mass Index |
4 | Arthritis |
4 | Anti-Inflammatory Agents, Non-Steroidal |
3 | Tumor Necrosis Factor Inhibitors |
3 | Treatment Failure |
3 | Th17 Cells |
3 | Spondylarthritis |
3 | Skin |
3 | Skin Neoplasms |
3 | Signal Transduction |
3 | Polymorphism, Single Nucleotide |
3 | Pain Measurement |
3 | Opportunistic Infections |
3 | Network Meta-Analysis |
3 | Neoplasms |
3 | Maintenance Chemotherapy |
3 | Lung |
3 | Longitudinal Studies |
3 | Leukocytes, Mononuclear |
3 | Interleukin 1 Receptor Antagonist Protein |
3 | Injections, Intravenous |
3 | Inflammatory Bowel Diseases |
3 | Immunoglobulins, Intravenous |
3 | Evidence-Based Medicine |
3 | Enzyme-Linked Immunosorbent Assay |
3 | Drug Hypersensitivity |
3 | Cytomegalovirus |
3 | Cross-Sectional Studies |
3 | Comorbidity |
3 | Collagen Type I |
3 | Certolizumab Pegol |
3 | Cell Proliferation |
3 | Bone and Bones |
3 | Blood Sedimentation |
3 | Autoimmune Diseases |
3 | Autoantibodies |
3 | Arthritis, Infectious |
3 | Aortitis |
3 | Antineoplastic Agents |
3 | Antigens, CD |
2 | Withholding Treatment |
2 | Vital Capacity |
2 | Virus Activation |
2 | Viral Load |
2 | Vasculitis |
2 | Ustekinumab |
2 | T-Lymphocyte Subsets |
2 | Systemic Vasculitis |
2 | Synovitis |
2 | Syndrome |
2 | Survival Analysis |
2 | Statistics, Nonparametric |
2 | Skin Diseases |
2 | Sjogren's Syndrome |
2 | Sirolimus |
2 | Sarcoidosis |
2 | Sampling Studies |
2 | Salvage Therapy |
2 | Quality of Life |
2 | Pyrroles |
2 | Pyrimidines |
2 | PubMed |
2 | Proportional Hazards Models |
2 | Practice Guidelines as Topic |
2 | Positron Emission Tomography Computed Tomography |
2 | Polyethylene Glycols |
2 | Pneumonia |
2 | Peptides |
2 | Peptides, Cyclic |
2 | Patient Safety |
2 | Osteocalcin |
2 | Neutrophils |
2 | Neuromyelitis Optica |
2 | Mutation |
2 | Mice, Inbred C57BL |
2 | Melanoma |
2 | Medication Therapy Management |
2 | Magnetic Resonance Imaging |
2 | Lymphoma |
2 | Logistic Models |
2 | Lipoproteins |
2 | Lipid Metabolism |
2 | Leflunomide |
2 | Knee Joint |
2 | Killer Cells, Natural |
2 | Kaplan-Meier Estimate |
2 | Interleukin-6 Receptor alpha Subunit |
2 | Interleukin-1beta |
2 | Interleukin-17 |
2 | Interleukin-10 |
2 | Induction Chemotherapy |
2 | Immunotherapy |
2 | Immunomodulation |
2 | Immunoglobulins |
2 | Immunoglobulin Fab Fragments |
2 | Hydroxymethylglutaryl-CoA Reductase Inhibitors |
2 | Hospitals, University |
2 | Herpesvirus 3, Human |
2 | Health Status |
2 | Hand Joints |
2 | Genetic Predisposition to Disease |
2 | Fluorodeoxyglucose F18 |
2 | Flow Cytometry |
2 | Fatigue |
2 | Edema |
2 | Drugs, Investigational |
2 | Drug Interactions |
2 | Drug Hypersensitivity Syndrome |
2 | Desensitization, Immunologic |
2 | Cytomegalovirus Infections |
2 | Crohn Disease |
2 | Critical Illness |
2 | Collagen Type II |
2 | Cell Line, Tumor |
2 | Case-Control Studies |
2 | Cartilage, Articular |
2 | CD4-Positive T-Lymphocytes |
2 | Body Weight |
2 | Biomarkers, Tumor |
2 | Bayes Theorem |
2 | Azathioprine |
2 | Arthritis, Psoriatic |
2 | Arthritis, Experimental |
2 | Arthralgia |
2 | Apyrase |
2 | Antineoplastic Agents, Immunological |
2 | Antifungal Agents |
2 | Anti-Bacterial Agents |
2 | Amyloidosis |
1 | Voriconazole |
1 | Vitrectomy |
1 | Vitiligo |
1 | Vitamins |
1 | Vitamin D |
1 | Visual Acuity |
1 | Vaccination |
1 | Uveal Neoplasms |
1 | United States |
1 | United Kingdom |
1 | Ultrasonography, Doppler |
1 | Tumor Necrosis Factors |
1 | Tumor Microenvironment |
1 | Tubulin Modulators |
1 | Tryptophan |
1 | Tretinoin |
1 | Trastuzumab |
1 | Transplantation, Homologous |
1 | Tomography, Optical Coherence |
1 | Toll-Like Receptors |
1 | Thrombin |
1 | Temporal Arteries |
1 | Tandem Mass Spectrometry |
1 | TNF-Related Apoptosis-Inducing Ligand |
1 | T-Lymphocytes |
1 | T-Lymphocytes, Cytotoxic |
1 | Symptom Assessment |
1 | Survival Rate |
1 | Superoxide Dismutase |
1 | Stomatitis, Aphthous |
1 | Steroids |
1 | Spinal Cord Compression |
1 | Societies, Medical |
1 | Smoking |
1 | Skin Tests |
1 | Sex Factors |
1 | Serum Amyloid A Protein |
1 | Sensory Receptor Cells |
1 | Sensitivity and Specificity |
1 | Semaphorins |
1 | Self Report |
1 | Secondary Prevention |
1 | Scleroderma, Diffuse |
1 | Scabies |
1 | Sarcoidosis, Pulmonary |
1 | Safety Management |
1 | STAT3 Transcription Factor |
1 | Risk |
1 | Risk Management |
1 | Rifampin |
1 | Rheumatology |
1 | Rheumatic Fever |
1 | Retreatment |
1 | Retina |
1 | Respiratory Insufficiency |
1 | Respiration, Artificial |
1 | Renal Replacement Therapy |
1 | Referral and Consultation |
1 | Reference Values |
1 | Receptors, Tumor Necrosis Factor |
1 | Receptors, Tumor Necrosis Factor, Type I |
1 | Receptors, Interleukin-1 Type I |
1 | Receptors, Chimeric Antigen |
1 | Receptors, Antigen, B-Cell |
1 | Real-Time Polymerase Chain Reaction |
1 | Rare Diseases |
1 | Range of Motion, Articular |
1 | Radiopharmaceuticals |
1 | Radionuclide Imaging |
1 | ROC Curve |
1 | RNA, Ribosomal, 16S |
1 | RNA, Neoplasm |
1 | Quinazolines |
1 | Quality Control |
1 | Pyrin |
1 | Pyrazoles |
1 | Pyrazines |
1 | Purpura, Thrombotic Thrombocytopenic |
1 | Pulmonary Fibrosis |
1 | Pulmonary Emphysema |
1 | Pulmonary Aspergillosis |
1 | Psychiatric Status Rating Scales |
1 | Proteolysis |
1 | Protein Kinase Inhibitors |
1 | Protein Array Analysis |
1 | Proof of Concept Study |
1 | Programmed Cell Death 1 Receptor |
1 | Procollagen |
1 | Primary Dysautonomias |
1 | Presenteeism |
1 | Prenatal Exposure Delayed Effects |
1 | Pregnancy |
1 | Pregnancy Outcome |
1 | Pregnancy Complications |
1 | Prednisolone |
1 | Predictive Value of Tests |
1 | Preconception Care |
1 | Precision Medicine |
1 | Polymerase Chain Reaction |
1 | Platelet-Rich Plasma |
1 | Platelet Aggregation |
1 | Plasmapheresis |
1 | Placebos |
1 | Piperidines |
1 | Pilot Projects |
1 | Pharyngitis |
1 | Peptide Fragments |
1 | Pedigree |
1 | Pediatrics |
1 | Patient-Centered Care |
1 | Patient Satisfaction |
1 | Patient Reported Outcome Measures |
1 | Patient Preference |
1 | Patient Participation |
1 | Patient Education as Topic |
1 | Pasteurella multocida |
1 | Pasteurella Infections |
1 | Parvovirus B19, Human |
1 | Pain |
1 | Pain Management |
1 | Overweight |
1 | Ovarian Neoplasms |
1 | Osteoporosis |
1 | Osteogenesis |
1 | Osteitis |
1 | Osmolar Concentration |
1 | Organic Anion Transporters |
1 | Oral Ulcer |
1 | Observational Studies as Topic |
1 | Nivolumab |
1 | Nevus |
1 | Neutropenia |
1 | Nervous System Diseases |
1 | Nerve Growth Factor |
1 | Nerve Fibers |
1 | Neoplasm Metastasis |
1 | Myositis |
1 | Myelodysplastic Syndromes |
1 | Myelitis |
1 | Myelin-Oligodendrocyte Glycoprotein |
1 | Mycophenolic Acid |
1 | Muscular Diseases |
1 | Multimodal Imaging |
1 | Monte Carlo Method |
1 | Monocytes |
1 | Mice, Transgenic |
1 | Mice, Knockout |
1 | Mice, Inbred NOD |
1 | Mice, Inbred DBA |
1 | Methylprednisolone |
1 | Mesenteric Ischemia |
1 | Meningoencephalitis |
1 | Meningococcal Vaccines |
1 | Meningitis |
1 | Meningitis, Aseptic |
1 | Matrix Metalloproteinase 3 |
1 | Maternal-Fetal Exchange |
1 | Magnetic Resonance Angiography |
1 | Macular Edema |
1 | Macrophages |
1 | Macrophage Activation |
1 | Lymphocytes, Tumor-Infiltrating |
1 | Lymphocyte Count |
1 | Lymphocyte Activation |
1 | Lymphadenopathy |
1 | Lupus Erythematosus, Systemic |
1 | Lung Neoplasms |
1 | Locomotion |
1 | Liver Neoplasms |
1 | Liver Failure |
1 | Liver Diseases |
1 | Lisuride |
1 | Lipoprotein(a) |
1 | Lipopolysaccharides |
1 | Lipids |
1 | Linear Models |
1 | Levofloxacin |
1 | Leukocyte Count |
1 | Leptin |
1 | Legionellosis |
1 | Legionellaceae |
1 | Leg |
1 | Lactation |
1 | Kidney Transplantation |
1 | Kidney Function Tests |
1 | Kidney Failure, Chronic |
1 | Janus Kinases |
1 | Ivermectin |
1 | Itraconazole |
1 | Isoxazoles |
1 | Isoantibodies |
1 | Ipilimumab |
1 | Internationality |
1 | International Cooperation |
1 | Internal Medicine |
1 | Interleukin-8 |
1 | Interleukin-33 |
1 | Interferons |
1 | Interferon-alpha |
1 | Intercellular Signaling Peptides and Proteins |
1 | Insulin Resistance |
1 | Injections, Intra-Articular |
1 | Infusion Pumps |
1 | Inflammation Mediators |
1 | Infections |
1 | Infant, Newborn |
1 | Indoles |
1 | Indoleamine-Pyrrole 2,3,-Dioxygenase |
1 | In Vitro Techniques |
1 | Immunotherapy, Adoptive |
1 | Immunophenotyping |
1 | Immunohistochemistry |
1 | Immunoglobulin G |
1 | Immunoglobulin E |
1 | Immunogenetics |
1 | Immunization |
1 | Immunity, Innate |
1 | Immune Tolerance |
1 | Illness Behavior |
1 | Ileitis |
1 | Hypothalamus |
1 | Hypertension |
1 | Hypertension, Pulmonary |
1 | Hypertension, Portal |
1 | Hydrogen-Ion Concentration |
1 | Hydrocortisone |
1 | Hydrocarbons |
1 | Hutchinson's Melanotic Freckle |
1 | Hospitals, Special |
1 | Hospitals, Pediatric |
1 | Hospitals, Community |
1 | Histoplasmosis |
1 | Histoplasma |
1 | Hidradenitis Suppurativa |
1 | Herpes Zoster |
1 | Herpes Zoster Vaccine |
1 | Herpes Zoster Ophthalmicus |
1 | Heredity |
1 | Hepatocytes |
1 | Hepatitis E |
1 | Hepatitis C, Chronic |
1 | Hepatitis B, Chronic |
1 | Hepatitis B Vaccines |
1 | Hepatic Stellate Cells |
1 | Hematopoietic Stem Cell Transplantation |
1 | Healthy Volunteers |
1 | Health Surveys |
1 | Health Expenditures |
1 | Haplotypes |
1 | Half-Life |
1 | Hair |
1 | HLA Antigens |
1 | Granzymes |
1 | Granuloma |
1 | Granulocyte-Macrophage Colony-Stimulating Factor |
1 | Graft Survival |
1 | Graft Rejection |
1 | Glomerulonephritis, IGA |
1 | Glomerular Filtration Rate |
1 | Genotype |
1 | Genetic Association Studies |
1 | Gene Regulatory Networks |
1 | Gene Expression Regulation, Enzymologic |
1 | Gene Expression Profiling |
1 | GTP-Binding Protein alpha Subunits, Gs |
1 | Foot Joints |